Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on: November 30,2024

Treatment advances and predictive biomarkers stand to improve bladder cancer care

byUniversity of North Carolina Health CareCredit: AI-generated imageRecent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk

Updated on:November 30,2024

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Updated on: March 25,2024

Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity

by Ehime UniversityMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Multiple myeloma is still an incurable hematological ma

Updated on:March 25,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on: December 01,2024

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring and treatment

byIndiana UniversityIU School of Medicine's Spyridon Bakas said the new recommendations are a much-needed update to the current standard of care in which individual radiologists measure tumo

Updated on:December 01,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on: November 10,2024

Clinical trial examines standard vs. extended lymph node removal for muscle-invasive bladder cancer

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainFinal results from the SWOG S1011 randomized Phase III clinical trial, published in theNew England Journal of Medicine, indicate p

Updated on:November 10,2024

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Updated on: January 26,2024

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Updated on:January 26,2024

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Updated on: January 11,2024

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Updated on:January 11,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on: March 20,2024

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on:March 20,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on: May 25,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on:May 25,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on: April 28,2024

AACR: Cadonilimab plus chemo beneficial for gastric adenocarcinoma

by Elana GotkineFor patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, ac

Updated on:April 28,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024